Endo ERN
Find an expert
Ukraine
Endo ERN
Search
  • Rare Endocrine Conditions

    Endocrine Conditions

    Endo-ERN is focused on 8 main thematic groups (MTGs) which cover rare and/or complex endocrine conditions

    Go to overview

    Categories

    • MTG1Adrenal
    • MTG2Disorders of Calcium & Phosphate Homeostasis
    • MTG3Genetic Disorders of Glucose & Insulin Homeostasis
    • MTG4Genetic Endocrine Tumour Syndromes
    • MTG5Growth & Genetic Obesity Syndromes
    • MTG6Hypothalamic and Pituitary Conditions
    • MTG7Sex Development & Maturation
    • MTG8Thyroid
  • About Us

    About Us

    Endo-ERN is a network of 100+ Reference Centres (RCs) in 27 EU member states+Norway that offers access to clinical experts for patients with rare endocrine conditions.  

    Go to overview

    Who we are

    • About Endo-ERN
    • What we do
    • Reference centres
    • Work packages
    • Project team

    Information

    • Events
    • FAQ
    • Newsletter
    • Contact
    • ERNs
  • For Professionals

    For Professionals

    Endo-ERN is the network for rare endocrine conditions providing healthcare professionals with access to a variety of resources to support patient care.  

    Our Network

    • About Endo-ERN
    • Find a Reference Centre

    Research

    • Registries
    • Publications
    • Clinical Trials

    Support Tools

    • Virtual Consultations
    • Guidelines
    • COVID-19

    Training & Education

    • Webinars
    • Exchange Programme
  • For Members

    For Members

    If you work at a member institution this page will help with your Endo-ERN contributions.  

    Go to overview

    Quick Links

    • Cite Endo-ERN
    • CPMS 2.0
    • GA2026
    • The Journal

    Evaluation

    • Continuous Monitoring Exercise
    • 5-year evaluation
    • HCP Performance System

    Network Participation

    • Event Endorsement
    • Member Survey
    • Webinar Planning
    • MTG Representatives

    Membership Management

    • Update Member Contacts
    • Request Disease Area Expansion
    • Termination Policy
  • For Patients

    For Patients

    Access to rare disease expertise without the need to travel is a core ERN objective.  Our ePAGs contribute to all Endo-ERN activities.  

    Go to overview

    Patient information

    • What are European Reference Networks?
    • Cross-border healthcare
    • Rare endocrine conditions
    • Patient materials

    ePAG information

    • European Patient Advocacy Groups
    • Patient representatives
    • How to become an Endo-ERN ePAG
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
Endo ERN
Ukraine
Find an expert
Search
/ Publications Overview / Publications Database

Endo-ERN Publications Database

RDD IssuesBack to Publications Overview

Filter list of publications

940 publication(s) found matching the search criteria

Alteraciones tiroideas asociadas con los inhibidores de los puntos de control inmunitario


Author(s): Fidilio E, Navarro-González E, Romero-Lluch AR, Iglesias P, Diez Gómez JJ, Anda Apiñániz E, Santos Mazo E, Zafón C
Affiliated Institution / ERN:
Condition / Disease: Thyroid dysfunction
Publication: Endocrinología, Diabetes y Nutrición v68.6 p408-415 Year: 2021 ORPHAcode / other:
DOI: 10.1016/j.endinu.2020.04.007 Keywords: Immune checkpoint inhibitors; Thyroid dysfunctionI; pilimumab, Nivolumab; Pembrolizumab; Hypothyroidism; Hyperthyroidism;
MTG8

The Value of Pre-Ablative I-131 Scan for Clinical Management in Patients With Differentiated Thyroid Carcinoma


Author(s): van der Boom T, Zandee WT, Dekkers CCJ, van der Horst-Schrivers ANA, Jansen L, Kruijff S, Brouwers AH, Links TP
Affiliated Institution / ERN: University Medical Center Groningen ; Maastricht University Medical Center+ ;
Condition / Disease: Follicular thyroid carcinoma
Publication: Frontiers in Endocrinology v12 Year: 2021 ORPHAcode / other: ORPHA146
DOI: 10.3389/fendo.2021.655676 Keywords: clinical management,differentiated thyroid carcinoma,postoperative I-131 diagnostic scan,thyroid cancer,uptake
MTG8

Using QR Code for Uniform Representation of Content in Cross-Border Exchange of ePrescriptions in the EU


Author(s): Krastev E, Kovachev P, Tcharaktchiev D, Abanos S
Affiliated Institution / ERN:
Condition / Disease:
Publication: Studies in Health Technology and Informatics doi:10.3233/shti210259 Year: 2021 ORPHAcode / other:
DOI: 10.3233/SHTI210259 Keywords: QR code,XML,business process model and notation,cross-border exchange,ePrescription,health informatics,inversion of control

Adults’ Adherence to Growth Hormone Replacement in Relation to Medication-Related Beliefs, Coping and Quality of Life – An Exploratory Analysis


Author(s): Siegel S, Unger N, Streetz-van der Werf C, Karges W, Schilbach K, Schröder B, Szybowicz J, Sauerwald J, Zopf K, Grzywotz A, Bidlingmaier M, Kirstein C, Sommer H, Strasburger CJ, Kreitschmann-Andermahr I
Affiliated Institution / ERN: University Hospital Essen ; University Hospital Aachen ; Klinikum der Universität München ; Charité Universitätsmedizin Berlin ;
Condition / Disease: Acquired and non-acquired hypopituitarism
Publication: Frontiers in Endocrinology v12 Year: 2021 ORPHAcode / other: ORPHA95488, ORPHA95502, ORPHA631
DOI: 10.3389/fendo.2021.680964 Keywords: adherence,adult growth hormone deficiency,beliefs about medications,coping,quality of life
MTG6

Thyroid Microcarcinoma in Pediatric Population in Romania


Author(s): Andreea-Ioana Stefan, Andra Piciu, Maria Margareta Cosnarovici, Monica Dragomir, Romana Netea-Maier, Doina Piciu
Affiliated Institution / ERN: Radboud University Medical Centre Nijmegen ; Institute of Oncology “Prof dr. Ion Chiricuta” CLUJ NAPOCA ;
Condition / Disease: Thyroid carcinoma
Publication: MDPI Children 2021, 8(5), 422; Year: 2021 ORPHAcode / other: ORPHA146
DOI: 10.3390/children8050422 Keywords: microcarcinoma; pediatric; thyroid cancer;
MTG8

Familial Short Stature—A Novel Phenotype of Growth Plate Collagenopathies


Author(s): Plachy L, Dusatkova P, Maratova K, Petruzelkova L, Elblova L, Kolouskova S, Snajderova M, Obermannova B, Zemkova D, Sumnik Z, Lebl J, Pruhova S
Affiliated Institution / ERN: ERN BOND ; Motol and Homolka University Hospital ;
Condition / Disease: Growth Plate Collagenopathies
Publication: The Journal of Clinical Endocrinology & Metabolism v106.6 p1742-1749 Year: 2021 ORPHAcode / other:
DOI: 10.1210/clinem/dgab084 Keywords: collagenopathies,familial short stature,growth hormone treatment,growth plate,next-generation sequencing
MTG5

Complete Remission of Advanced Adrenocortical Cancer Following Mitotane Monotherapy: A Case Report and Literature Review of Predictive Markers


Author(s): Tőke J, Jakab Z, Stark J, Huszty G, Reismann P, Tóth M
Affiliated Institution / ERN: Semmelweis University ;
Condition / Disease: Adrenocortical carcinoma
Publication: Frontiers in Oncology v11 Year: 2021 ORPHAcode / other: ORPHA1501
DOI: 10.3389/fonc.2021.680853 Keywords: adrenocortical cancer,complete remission,mitotane,monotherapy,predictive markers
MTG1

Current Status of Newborn Screening in Southeastern Europe


Author(s): Koracin V, Mlinaric M, Baric I, Brincat I, Djordjevic M, Drole Torkar A, Fumic K, Kocova M, Milenkovic T, Moldovanu F, Mulliqi Kotori V, Nanu MI, Remec ZI, Repic Lampret B, Platis D, Savov A, Samardzic M, Suzic B, Szatmari I, Toromanovic A, Zerjav Tansek M, Battelino T, Groselj U
Affiliated Institution / ERN: ERN BOND ;
Condition / Disease: Newborn screening
Publication: Frontiers in Pediatrics v9 Year: 2021 ORPHAcode / other: ORPHA442, ORPHA418
DOI: 10.3389/fped.2021.648939 Keywords: NBS,dried blood sample,expanded NBS program,neonatal screening,newborn screening,southeastern Europe,survey
MTG1 MTG7 MTG8

Lower HbA1c targets are associated with better metabolic control


Author(s): Van Loocke M, Battelino T, Tittel SR, Prahalad P, Goksen D, Davis E, Casteels K
Affiliated Institution / ERN: UZ Leuven ; University Medical Centre Ljubljana ; Ulm University Medical Center ;
Condition / Disease: Diabetes mellitus
Publication: European Journal of Pediatrics v180.5 p1513-1520 Year: 2021 ORPHAcode / other: ORPHA101952
DOI: 10.1007/s00431-020-03891-2 Keywords: Children,HbA1c,Metabolic control,SWEET
MTG3

A simplified primary aldosteronism surgical outcome score is a useful prediction model when target organ damage is unknown – Retrospective cohort study


Author(s): Suurd DP, Visscher WP, Vorselaars WM, van Beek D, Spiering W, Borel Rinkes IH, Valk GD, Vriens MR, Zarnegar R, Fahey TJ, Duh QY, Shen WT, Drake FT, McAneny DB, McManus C, Lee JA, Grant SB, Grogan RH, Romero Arenas MA, Perrier ND, Sturgeon C, Castelino T, Mitmaker EJ, Parente DN, Pasternak JD, Sidhu SB, Sywak M, D'Amato G, Raffaelli M, Schuermans V, Bouvy ND, Eker HH, Bonjer JH, Engelsman AF, van Dijkum EJN, Kerstens MN, Kruijff S
Affiliated Institution / ERN: Hospital Universitario Cruces ; Karolinska University Hospital ; IRCCS Istituto Giannina Gaslini, Genova ; General Hospital of Athens “LAIKO” ;
Condition / Disease: Primary aldosteronism
Publication: Annals of Medicine & Surgery v65 Year: 2021 ORPHAcode / other: ORPHA181415
DOI: 10.1016/j.amsu.2021.102333 Keywords: Adrenalectomy,Blood pressure,Endocrine surgery,Hypertension,PASO score,Primary aldosteronism
MTG1

The diagnostic accuracy of adjusted unconventional indices for adrenal vein sampling in the diagnosis of primary aldosteronism subtypes


Author(s): Parasiliti-Caprino M, Bioletto F, Ceccato F, Lopez C, Bollati M, Voltan G, Rossato D, Giraudo G, Scaroni C, Ghigo E, Maccario M
Affiliated Institution / ERN: AO City of Health and Science - Turin ; University Hospital of Padova ;
Condition / Disease: Primary aldosteronism
Publication: Journal of Hypertension v39.5 p1025-1033 Year: 2021 ORPHAcode / other: ORPHA181415
DOI: 10.1097/HJH.0000000000002700 Keywords:
MTG1

Worse glycemic control, higher rates of diabetic ketoacidosis, and more hospitalizations in children, adolescents, and young adults with type 1 diabetes and anxiety disorders


Author(s): Galler A, Tittel SR, Baumeister H, Reinauer C, Brosig B, Becker M, Haberland H, Hilgard D, Jivan M, Mirza J, Schwab J, Holl RW
Affiliated Institution / ERN: Charité Universitätsmedizin Berlin ; Ulm University Medical Center ; Klinikum der Universität München ; Universitätsklinikum Düsseldorf ; Centre Hospitalier de Luxembourg ;
Condition / Disease: Type 1 Diabetes Mellitus
Publication: Pediatric Diabetes v22.3 p519-528 Year: 2021 ORPHAcode / other: 5A10
DOI: 10.1111/pedi.13177 Keywords:
MTG3

A Comparison of Familial and Sporadic Type 1 Diabetes Among Young Patients


Author(s): Karges B, Prinz N, Placzek K, Datz N, Papsch M, Strier U, Agena D, Bonfig W, Kentrup H, Holl RW
Affiliated Institution / ERN: University Hospital Aachen ; Ulm University Medical Center ; Hannoversche Kinderheilanstalt ; Klinikum Wels Grieskirchen ;
Condition / Disease: Type 1 diabetes mellitus
Publication: Diabetes Care v44.5 p1116-1124 Year: 2021 ORPHAcode / other: 5A10
DOI: 10.2337/dc20-1829 Keywords:
MTG3

Lifetime impact of achondroplasia: Current evidence and perspectives on the natural history


Author(s): Hoover-Fong J, Cheung MS, Fano V, Hagenas L, Hecht JT, Ireland P, Irving M, Mohnike K, Offiah AC, Okenfuss E, Ozono K, Raggio C, Tofts L, Kelly D, Shediac R, Pan W, Savarirayan R
Affiliated Institution / ERN: Merkur University Hospital ; ERN BOND ;
Condition / Disease: Achondroplasia
Publication: Bone v146 p115872 Year: 2021 ORPHAcode / other: ORPHA15
DOI: 10.1016/j.bone.2021.115872 Keywords: Achondroplasia,Cervicomedullary decompression,Fibroblast growth factor receptor 3 (FGFR3),Foramen magnum stenosis,Genu varum,Natural history,Skeletal dysplasia

In vitro effects of the endocrine disruptor p,p′DDT on human choriogonadotropin/luteinizing hormone receptor signalling


Author(s): Munier M, Ayoub M, Suteau V, Gourdin L, Henrion D, Reiter E, Rodien P
Affiliated Institution / ERN:
Condition / Disease:
Publication: Archives of Toxicology v95.5 p1671-1681 Year: 2021 ORPHAcode / other:
DOI: 10.1007/s00204-021-03007-1 Keywords: DDT,Endocrine disrupting chemical,HCG/LHR signaling,Steroidogenesis

Gender incongruence and gender dysphoria in childhood and adolescence—current insights in diagnostics, management, and follow-up


Author(s): Claahsen - van der Grinten H, Verhaak C, Steensma T, Middelberg T, Roeffen J, Klink D
Affiliated Institution / ERN: Radboud University Medical Centre Nijmegen ; Amsterdam UMC ; University Medical Center Groningen ; Ghent University Hospital ;
Condition / Disease: Gender dysphoria
Publication: European Journal of Pediatrics v180.5 p1349-1357 Year: 2021 ORPHAcode / other: F64
DOI: 10.1007/s00431-020-03906-y Keywords: Gender dysphoria,Gender incongruence,Gender-affirming treatment,Pubertal suppression,Transgender care
MTG7

Nodal metastatic load in papillary thyroid carcinoma. Morphological and molecular analysis with one-step nucleic acid amplification on more than 550 lymph nodes


Author(s): Iglesias C, González O, Temprana-Salvador J, García-Burillo A, Caubet E, Ramón y Cajal S, Zafon C
Affiliated Institution / ERN:
Condition / Disease: Follicular thyroid carcinoma
Publication: Endocrinología, Diabetes y Nutrición v68.5 p346-353 Year: 2021 ORPHAcode / other: ORPHA146
DOI: 10.1016/j.endinu.2020.04.004 Keywords: Carcinoma de tiroides,Linfadenectomía,Lymph node metastasis,Lymphadenectomy,Metástasis linfática,OSNA,Thyroid carcinoma
MTG8

Women’s perceptions of femininity after craniopharyngioma: a qualitative study


Author(s): Eydoux R, Castinetti F, Authier M, Vialle M, Albarel F, Brue T, Courbiere B
Affiliated Institution / ERN:
Condition / Disease: Craniopharyngioma
Publication: Clinical Endocrinology v94.5 p880-887 Year: 2021 ORPHAcode / other: ORPHA54595
DOI: 10.1111/cen.14378 Keywords: Craniopharyngioma,body image,femininity,infertility,intimacy,qualitative study,sexuality
MTG6

Is there any gender difference in epidemiology, clinical presentation and co-morbidities of non-functioning pituitary adenomas? A prospective survey of a National Referral Center and review of the literature


Author(s): Di Somma C, Scarano E, de Alteriis G, Barrea L, Riccio E, Arianna R, Savastano S, Colao A
Affiliated Institution / ERN: AOU Federico II - Naples ;
Condition / Disease: Non-functioning pituitary adenoma
Publication: Journal of Endocrinological Investigation v44.5 p957-968 Year: 2021 ORPHAcode / other: ORPHA91349
DOI: 10.1007/s40618-020-01379-2 Keywords: Cardio-metabolic indices,Gender differences,Hypopituitarism,Metabolic syndrome,NFPA,Tumor size
MTG6

Case Report: Complete Necrosis of a Large Adrenocortical Cancer and Liver Metastases Achieved by Selective Arterial Embolization: A Case Study and Review of Literature


Author(s): Huszty G, Doros A, Farkas K, Kóbori L, Reismann P, Tőke J, Tóth M, Igaz P
Affiliated Institution / ERN: Semmelweis University ;
Condition / Disease: Adrenocortical carcinoma
Publication: Frontiers in Endocrinology v12 Year: 2021 ORPHAcode / other: ORPHA1501
DOI: 10.3389/fendo.2021.677187 Keywords: adrenocortical cancer,embolization,liver metastasis,necrosis,trans-arterial
MTG1

Novel mutations in the WFS1 gene are associated with Wolfram syndrome and systemic inflammation


Author(s): Panfili E, Mondanelli G, Orabona C, Belladonna ML, Gargaro M, Fallarino F, Orecchini E, Prontera P, Proietti E, Frontino G, Tirelli E, Iacono A, Vacca C, Puccetti P, Grohmann U, Esposito S, Pallotta MT
Affiliated Institution / ERN: San Raffaele hospital - Milan ;
Condition / Disease: Wolfram syndrome
Publication: Human Molecular Genetics v30.3-4 p265-276 Year: 2021 ORPHAcode / other: ORPHA3463
DOI: 10.1093/hmg/ddab040 Keywords:
MTG6

Approach to the Virilizing Girl at Puberty


Author(s): Santi M, Graf S, Zeino M, Cools M, Van De Vijver K, Trippel M, Aliu N, Flück CE
Affiliated Institution / ERN:
Condition / Disease: 46,XX DSD
Publication: The Journal of Clinical Endocrinology & Metabolism v106.5 p1530-1539 Year: 2021 ORPHAcode / other: ORPHA2928
DOI: 10.1210/clinem/dgaa948 Keywords: androgen excess,disorders/differences of sex development (DSD),endocrine active tumors,genetic disorders of androgen excess,virilization
MTG7

Obesity in Prader–Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches


Author(s): Muscogiuri G, Barrea L, Faggiano F, Maiorino MI, Parrillo M, Pugliese G, Ruggeri RM, Scarano E, Savastano S, Colao A
Affiliated Institution / ERN: AOU Federico II - Naples ; AOU University of Campania "Luigi Vanvitelli", Naples ; AOU polyclinic "G.Martino" of Messina ;
Condition / Disease: Prader-Willi syndrome
Publication: Journal of Endocrinological Investigation v44.10 p2057-2070 Year: 2021 ORPHAcode / other: ORPHA739
DOI: 10.1007/s40618-021-01574-9 Keywords: Diabetes mellitus,Hyperphagia,Obesity,Prader–Willi syndrome
MTG5

Growth Restriction and Genomic Imprinting-Overlapping Phenotypes Support the Concept of an Imprinting Network


Author(s): Eggermann T, Davies JH, Tauber M, van den Akker E, Hokken-Koelega A, Johansson G, Netchine I
Affiliated Institution / ERN: University Hospital Aachen ; CHU de Toulouse ; Erasmus MC: University Medical Center Rotterdam ; Sahlgrenska University Hospital ;
Condition / Disease: Imprinting disorders and growth disturbance
Publication: Genes v12.4 p585 Year: 2021 ORPHAcode / other: ORPHA739, ORPHA813, ORPHA254516, ORPHA94089
DOI: 10.3390/genes12040585 Keywords: Prader-Willi syndrome,Silver-Russell syndrome,differentially methylated regions,growth restriction,imprinted gene network,imprinting disorders,overgrowth,pseudoparahypoparathyreoidism,temple syndrome,transient neonatal diabetes
MTG5

High Prevalence of Weight Gain in Childhood Brain Tumor Survivors and Its Association With Hypothalamic-Pituitary Dysfunction


Author(s): van Schaik J, van Roessel IMAA, Schouten-van Meeteren NAYN, van Iersel L, Clement SC, Boot AM, Claahsen-van der Grinten HL, Fiocco M, Janssens GO, van Vuurden DG, Michiels EM, Han SKS, van Trotsenburg PASP, Vandertop PWP, Kremer LCM, van Santen HM
Affiliated Institution / ERN: University Medical Center Utrecht ; Amsterdam UMC ; University Medical Center Groningen ; Radboud University Medical Centre Nijmegen ; Leiden University Medical Center ;
Condition / Disease: Hypothalamic-Pituitary Dysfunction
Publication: Journal of Clinical Oncology v39.11 p1264-1273 Year: 2021 ORPHAcode / other: ORPHA95503, ORPHA54595, ORPHA99408
DOI: 10.1200/JCO.20.01765 Keywords:
MTG6

Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%?


Author(s): Merola E, Alonso Gordoa T, Zhang P, Al-Toubah T, Pellè E, Kolasińska-Ćwikła A, Zandee W, Laskaratos F, Mestier L, Lamarca A, Hernando J, Cwikla J, Strosberg J, Herder W, Caplin M, Cives M, Leeuwaarde R
Affiliated Institution / ERN: ERN BOND ;
Condition / Disease: Pancreatic neuroendocrine neoplasms
Publication: The Oncologist v26.4 p294-301 Year: 2021 ORPHAcode / other: ORPHA97253
DOI: 10.1002/onco.13633 Keywords: G2,G3,Hepatic tumor load,Lanreotide,Octreotide,Pancreatic neuroendocrine tumor

Congenital hypothyroidism and hearing loss without inner ear malformation: Think TPO


Author(s): Ziegler A, Denommé‐Pichon A, Boucher S, Bouzamondo N, Colin E, Dieu X, Jean Yves T, Bouhours N, Rouleau S, Coutant R, Rodien P, Prunier D, Bonneau D
Affiliated Institution / ERN: CHU d'Angers ;
Condition / Disease: Congenital hypothyroidism
Publication: Clinical Genetics v99.4 p604-606 Year: 2021 ORPHAcode / other: ORPHA442
DOI: 10.1111/cge.13902 Keywords:
MTG8

SRY‐negative 46,XX testicular/ovotesticular DSD: Long‐term outcomes and early blockade of gonadotropic axis


Author(s): Lambert S, Peycelon M, Samara‐Boustani D, Hyon C, Dumeige L, Peuchmaur M, Fiot E, Léger J, Simon D, Paye‐Jaouen A, Bouligand J, Siffroi J, Carel J, McElreavey K, El Ghoneimi A, Brachet C, Bouvattier C, Martinerie L
Affiliated Institution / ERN: Assistance Publique-Hôpitaux de Paris, Hôpital Cochin ; University Hospital Liège ; Hôpital Universitaire de Bruxelles (HUDERF-Erasme) ; Hôpital Bicêtre ;
Condition / Disease: Ovotesticular DSD
Publication: Clinical Endocrinology v94.4 p667-676 Year: 2021 ORPHAcode / other: ORPHA2138
DOI: 10.1111/cen.14389 Keywords: 46,XX-SRY-negative DSD,GnRH analog,minipuberty,ovotesticular DSD,testicular DSD
MTG7

HOMA-IR in acromegaly: a systematic review and meta-analysis


Author(s): Biagetti B, Aulinas A, Casteras A, Pérez-Hoyos S, Simó R
Affiliated Institution / ERN: Hospital Universitari Vall d’Hebron ; Hospital de la Santa Creu i Sant Pau ;
Condition / Disease: Acromegaly
Publication: Pituitary v24.2 p146-158 Year: 2021 ORPHAcode / other: ORPHA963
DOI: 10.1007/s11102-020-01092-6 Keywords: Acromegaly,Diabetes mellitus,HOMA,Insulin resistance,Meta-analysis
MTG6

Generation and Differentiation of Adult Tissue-Derived Human Thyroid Organoids


Author(s): Ogundipe VM, Groen AH, Hosper N, Nagle PW, Hess J, Faber H, Jellema AL, Baanstra M, Links TP, Unger K, Plukker JT, Coppes RP
Affiliated Institution / ERN: Klinikum der Universität München ; University Medical Center Groningen ;
Condition / Disease: Thyroid regeneration
Publication: Stem Cell Reports v16.4 p913-925 Year: 2021 ORPHAcode / other:
DOI: 10.1016/j.stemcr.2021.02.011 Keywords: hypothyroidism,regeneration,stem cells,thyroglobulin,thyroid cancer,thyroid-tissue-derived organoids,xeno-transplanation
MTG8
Page 21 of 32« First«...10...1920212223...30...»Last »

Endo-ERN Newsletter

Subscribe to our newsletter to receive updates on all network activities and new resources. As soon as you subscribe you will receive an email asking you to confirm your registration.

SIGN UP NOW

News

  • All news
  • Newsletter signup

Events

  • Upcoming events
  • Webinars

Information

  • About Us
  • Contact
  • FAQs

Social Links

Linkedin Facebook Youtube

Contact

Endo-ERN
Coordinating Center
Meibergdreef 9
1105 AZ AMSTERDAM
The Netherlands

info@endo-ern.eu
Funded by the European Union
©2026. All Rights Reserved. Endo-ERN

Privacy Policy – GDPR

Website design by Elan Creative

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Information video for patients and healthcare professionals

Type and Press “enter” to Search

Search
Privacy Overview
Endo-ERN

Endo-ERN Privacy Policy

Endo-ERN is committed to user’s privacy and does not track personal data when visiting our website. We act in accordance with Regulation 2016/679 of the European Parliament and of the Council.

‘Personal data’ means any information relating to an identified or identifiable natural person. An identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as:

  • a name
  • an identification number
  • location data
  • an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person

Cookies

Endo-ERN only tracks anonymised data for statistical purposes. We do this via analytical cookies, placed through an anonymous IP Google analytics tag. The purpose of these cookies are to track the efficiency and success of the website.

These cookies do not store any personal data that can be linked to a natural person, but may save data such as inter alia, data about the website from which a person has come (the so-called referrer), which sub-pages were visited, or how often and for what duration a sub-page was viewed. The data collected through this is general data only, and cannot be traced back to one person.

It is possible to prevent the setting of cookies, by means of a setting of the Internet browser used. On top of that, already set cookies may be deleted at any time via an Internet browser or other software programs. This is possible in all popular Internet browsers.

Google Analytics does not share any data with third parties.

The principles of data protection do not apply to anonymous information and because these cookies minimally impact the privacy of the user, it is not necessary to ask for permission to use these cookies.

Newsletter

You may always unsubscribe from our newsletter at any time through the unsubscribe button located in our newsletter. Endo-ERN is both the controller and responsible for processing of any data regarding the newsletter. Endo-ERN does not make use of a third party for the Newsletter service.

E-services

Endo-ERN has a contact form, which activates your email software and allows you to send a comment or question to a general email address. When you send such a message, your personal data is collected only to the extent necessary to reply. If the team responsible for the mailbox is unable to answer your question, or your questions has regards to another party, it might forward your email to another service.

If you have any questions about the processing of your email and related personal data, do not hesitate to include them in your message.

The collected personal data and all information related to the above mentioned consultation is stored on the email server of the Endo-ERN Coordinating office and potentially those who have been concerned in the correspondence in order to respond to your comment.

Newsletter Tracking

The Endo-ERN newsletter makes use of tracking in order to be able to conduct a statistical analysis of the success or failure of online marketing campaigns. Endo-ERN may see if an email containing a newsletter was opened by a user, when it was opened, and which links were opened. 
The data collected through this tracking is generated and stored by Endo-ERN and is not shared with third parties, but may be used to adapt future content of newsletters in order to better meet the interests of our subscribers.

Contact details

For any questions regarding our privacy policy, please contact the Endo-ERN coordinating office.

You have the right to be forgotten and removed completely from the Endo-ERN contact database. To request this, please contact the Endo-ERN coordinating office.

Endo-ERN Coordinating Center, Meibergdreef 9, 1105 AZ  AMSTERDAM. The Netherlands

 info@endo-ern.eu
Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Powered by  GDPR Cookie Compliance